Key result
Oral supplementation with ascorbate and alpha-tocopherol for 165 days reversed endothelial dysfunction in smokers, restoring flow-mediated dilation to levels comparable with healthy controls (P<0.05).
Why the study?
Does long-term antioxidant supplementation with ascorbate and alpha-tocopherol improve endothelial dysfunction in smokers?
Does long-term antioxidant supplementation with ascorbate and alpha-tocopherol improve endothelial dysfunction in smokers?
Long-term antioxidant supplementation with ascorbate and alpha-tocopherol reverses endothelial dysfunction in smokers by mitigating superoxide-mediated nitric oxide inactivation.
Answers are grounded in this paper and cite their sources.
Suggests long-term antioxidant therapy may improve vascular health in smokers; leaves open whether.
Tobacco smoke is known to cause nitric oxide ((*)NO) inactivation and endothelial dysfunction. In this work we evaluated the interplay between (.)NO and superoxide (O(2)(*-)) radicals and the consequent impact on (*)NO bioavailability and nitroxidative stress in bovine aortic endothelial cells exposed to cigarette smoke extract (CSE) and in smokers. Bovine aortic endothelial cells in the presence of CSE triggered O(2)(*-) production as indicated by spin-trapping electron paramagnetic resonance experiments. O(2)(*-) was produced both extracellulary (3.4 vs. 1.0 nmol.h(-1)*mg(-1); CSE vs. control; cytochrome c(3+) reduction assay) and intracellularly (40% inhibition of cytosolic aconitase). CSE also led to the production of peroxynitrite as evaluated by dihydrorhodamine oxidation and protein tyrosine nitration on cells. O(2)(*-) and peroxynitrite formation were decreased by ascorbate and alpha-tocopherol. Additionally, CSE led to the oxidation of endothelial nitric oxide synthase increasing the monomeric inactive form of endothelial nitric oxide synthase. Smokers and age-matched healthy volunteers were supplemented orally with 500 mg ascorbate plus 400 IU all-rac-alpha-tocopherol every 12 h for 165 days. Smokers had endothelial dysfunction compared with control subjects (95% confidence interval: 2.5, 8.3 vs. 10.6, 14.2; P < 0.05) as assessed by flow-mediated dilation of the brachial artery, and plasma levels of protein 3-nitrotyrosine were 1.4-fold higher. The loss of flow-mediated dilation in smokers reverted after a long-term antioxidant supplementation (95% confidence interval: 13.9, 19.9; P < 0.05), reaching values comparable with the control population. Our data indicate that elements on tobacco smoke, most likely through redox cycling, divert (*)NO toward peroxynitrite by inducing O(2)(*-) production in vascular endothelial cells both in vitro and in vivo.
No takes yet. Share an insight, caveat, or question.
Peluffo et al. (2009) studied Endothelial dysfunction in smokers. Ascorbate plus all-rac-alpha-tocopherol vs. Healthy volunteers was evaluated on Flow-mediated dilation of the brachial artery (p=< 0.05). Oral supplementation with ascorbate and alpha-tocopherol for 165 days reversed endothelial dysfunction in smokers, restoring flow-mediated dilation to levels comparable with healthy controls (P<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: